Therefore, annual x-rays thereafter are very useful in charting the progression of the disease
Adems se observaron mejoras significativas en niveles de enzimas hepticas, tensin arterial, triglicridos y metabolismo de la glucosa: 95,3% de los participantes con prediabetes normalizaron su metabolismo glucmico (vs 61,9% en grupo placebo) En cuanto a los efectos adversos gastrointestinales, el porcentaje de discontinuacin fue: 4,3% (5 mg), 7,1% (10 mg), 6,2% (15 mg) vs 2,6 (placebo)
Novo Nordisk is currently running two large Phase 3 trials to investigate the effect of GLP-1 drugs on Alzheimer's disease, based on early data suggesting reduced neuroinflammation, improved cognition and function, and enhanced memory, as well as trials in which GLP-1 drugs appeared to substantially reduce dementia rates in diabetes patients
Yousseif et al., 2014)
Pricing reflects the high-quality medical environment and the physician oversight provided within Dr
Median OS was not reached in either pembrolizumab group
